Changes in Hormonal Profile and Body Mass Index in Women With Polycystic Ovary Syndrome After Probiotic Intake
Changes in Hormonal Profile and Body Mass Index in Women With Polycystic Ovary Syndrome After Probiotic Intake: A 12-week Placebo Controlled and Randomized Clinical Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Szczecin, Poland
- Pomeranian Medical University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- women with PCOS, diagnosed based on Rotterdam ESHRE criteria
Exclusion Criteria:
- The patients with comorbidities such as diabetes mellitus type I and II, heart diseas-es, liver diseases, hypertension, hypothyroidism should be excluded from the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Probiotics Intake
The probiotic group received SanProbi® Barrier capsules
|
The probiotic group received SanProbi® Barrier capsules
|
|
Placebo Comparator: Placebo Intake
The placebo group received capsules filled mainly with maize starch and maltodextrins.
|
The placebo group received capsules filled mainly with maize starch and maltodextrins.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in hormonal profile after probiotics intake
Time Frame: 12 weeks
|
The hormones will be measured before and after 12-week intervention: the main outcome measure will be androstenedione, prolactin, 17-hydroxyprogesterone and testosterone levels measured in ng/ml.
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in FSH and LH levels in women with polycystic ovary syndrome after probiotic intake
Time Frame: 12 weeks
|
LH and FSH levels will be measured before and after 12 weeks of probiotics intake.
They are measured in mIU/ml
|
12 weeks
|
|
Change in Estradiol levels in women with polycystic ovary syndrome after probiotic intake
Time Frame: 12 weeks
|
Estradiol levels will be measured before and after 12 weeks of probiotics intake.
They are measured in pg/ml
|
12 weeks
|
|
Changes in TSH levels in women with polycystic ovary syndrome after probiotic intake
Time Frame: 12 weeks
|
TSH levels will be measured before and after 12 weeks of probiotics intake.
They are measured in μIU/ml
|
12 weeks
|
|
Changes in SHBG in women with polycystic ovary syndrome after probiotic intake
Time Frame: 12 weeks
|
SHBG levels will be measured before and after 12 weeks of probiotics intake.
They are measured in nmol/l
|
12 weeks
|
|
Changes in DHEA-S levels in women with polycystic ovary syndrome after probiotic intake
Time Frame: 12 weeks
|
DHEA-S levels will be measured before and after 12 weeks of probiotics intake.
They are measured in μg/dl
|
12 weeks
|
|
Changes in BMI in women with polycystic ovary syndrome after probiotic intake
Time Frame: 12 weeks
|
BMI will be measured before and after 12 weeks of probiotics intake.
Weight and height will be combined to report BMI in kg/m^2
|
12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1/12/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.